Activation of blood coagulation in plasma from chronic urticaria patients with negative autologous plasma skin test
- 4 January 2011
- journal article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 25 (2), 201-205
- https://doi.org/10.1111/j.1468-3083.2010.03752.x
Abstract
Background Skin reactivity to the intradermal injection of autologous serum (autologous serum skin test – ASST) and/or plasma (autologous plasma skin test – APST) is thought to identify chronic urticaria (CU) patients with an autoimmune/autoreactive disease. Immune‐mediated inflammation and coagulation are strictly linked, and coagulation activation has been described in CU patients as shown by the elevation of plasma prothrombin fragment F1 + 2 and, in severe cases, of d‐dimer as well. Objective The aim of this study was to evaluate whether the coagulation cascade is activated in APST‐negative CU patients as it has been described in CU patients with an autoreactive disease. Methods A total of 43 adults with CU (M/F 15/28; mean age 43.5 years; 16 APST‐negative patients and 27 APST‐positive) and 30 healthy subjects were studied. Prothrombin fragment F1 + 2, d‐dimer and C‐reactive protein (CRP) plasma levels were measured by ELISA. Results Prothrombin fragment F1 + 2 and d‐dimer were elevated in seven of 16 APST‐negative CU patients. The activation of the coagulation cascade was associated with disease severity. Men were more prevalent in idiopathic than in autoreactive CU patients (M/F: 10/6 vs. 5/22; P < 0.001). In patients with APST‐negative CU, mean F1 + 2 level [242.8 ± 33.7 pmol/L (ESM)] was higher than in normal controls (151.8 ± 9.09 pmol/L; P = 0.002) but lower than in autoreactive patients (526.2 ± 97.8 pmol/L; P = 0.05). Similarly, mean d‐dimer level was higher than in normal controls (484.2 ± 148.3 ng/mL vs. 229.5 ± 16.7 ng/mL; P = 0.03) but lower than in autoreactive patients (1142.2 ± 317.4 ng/mL; P = 0.05). In contrast, mean CRP was lower than in autoreactive patients (1.06 ± 0.32 μg/mL vs. 3.09 ± 0.74 μg/mL; P = 0.02) but not different from normal subjects (0.78 ± 0.09 μg/mL; NS). Conclusion Autologous plasma skin test‐negative CU prevails in men; in these patients the coagulation cascade is activated although with a lower intensity than in patients with autoreactive disease.Keywords
This publication has 21 references indexed in Scilit:
- Expression of Tissue Factor by Eosinophils in Patients with Chronic UrticariaInternational Archives of Allergy and Immunology, 2008
- Severe chronic urticaria is associated with elevated plasma levels of D‐dimerAllergy, 2008
- Efficacy and safety of desloratadine combined with dipyridamole in the treatment of chronic urticariaJournal of the European Academy of Dermatology and Venereology, 2007
- Plasma of patients with chronic urticaria shows signs of thrombin generation, and its intradermal injection causes wheal-and-flare reactions much more frequently than autologous serumJournal of Allergy and Clinical Immunology, 2006
- Comparative studies of functional and binding assays for IgG anti-FcϵRIα (α-subunit) in chronic urticariaJournal of Allergy and Clinical Immunology, 1998
- Not all chronic urticaria is “idiopathic”Experimental Dermatology, 1998
- Thrombin functions as an inflammatory mediator through activation of its receptor.The Journal of Experimental Medicine, 1996
- Serum IgG autoantibodies directed against the alpha chain of Fc epsilon RI: a selective marker and pathogenetic factor for a distinct subset of chronic urticaria patients?JCI Insight, 1995
- Detection of circulating histamine releasing autoantibodies with functional properties of anti‐IgE in chronic urticariaClinical and Experimental Allergy, 1991
- Prevalence and Functional Role of Anti-IgE Autoantibodies in Urticarial SyndromesJournal of Investigative Dermatology, 1988